Review
Oncology
Matteo Lambertini, Eva Blondeaux, Marco Bruzzone, Marta Perachino, Richard A. Anderson, Evandro de Azambuja, Philip D. Poorvu, Hee Jeong Kim, Cynthia Villarreal-Garza, Barbara Pistilli, Ines Vaz-Luis, Cristina Saura, Kathryn J. Ruddy, Maria Alice Franzoi, Chiara Sertoli, Marcello Ceppi, Hatem A. Azim, Frederic Amant, Isabelle Demeestere, Lucia Del Mastro, Ann H. Partridge, Olivia Pagani, Fedro A. Peccatori
Summary: This study found that breast cancer survivors are less likely to have a subsequent pregnancy compared to the general population, and they face higher risks during pregnancy, especially among those who have received chemotherapy. However, compared to breast cancer patients without subsequent pregnancy, those who become pregnant have better disease-free survival and overall survival rates.
JOURNAL OF CLINICAL ONCOLOGY
(2021)
Review
Oncology
Margarita Cariolou, Leila Abar, Dagfinn Aune, Katia Balducci, Nerea Becerra-Tomas, Darren C. Greenwood, Georgios Markozannes, Neesha Nanu, Rita Vieira, Edward L. Giovannucci, Marc J. Gunter, Alan A. Jackson, Ellen Kampman, Vivien Lund, Kate Allen, Nigel T. Brockton, Helen Croker, Daphne Katsikioti, Deirdre McGinley-Gieser, Panagiota Mitrou, Martin Wiseman, Amanda J. Cross, Elio Riboli, Steven K. Clinton, Anne McTiernan, Teresa Norat, Konstantinos K. Tsilidis, Doris S. M. Chan
Summary: This study conducted a systematic review and meta-analyses to examine the associations between physical activity and breast cancer prognosis. The results showed that moderate physical activity was associated with lower all-cause and breast cancer-specific mortality, but had no significant effect on breast cancer recurrence. Furthermore, the study found that the benefits of physical activity plateaued after reaching a certain level.
INTERNATIONAL JOURNAL OF CANCER
(2023)
Review
Oncology
Doris S. M. Chan, Rita Vieira, Leila Abar, Dagfinn Aune, Katia Balducci, Margarita Cariolou, Darren C. Greenwood, Georgios Markozannes, Neesha Nanu, Nerea Becerra-Tomas, Edward L. Giovannucci, Marc J. Gunter, Alan A. Jackson, Ellen Kampman, Vivien Lund, Kate Allen, Nigel T. Brockton, Helen Croker, Daphne Katsikioti, Deirdre McGinley-Gieser, Panagiota Mitrou, Martin Wiseman, Amanda J. Cross, Elio Riboli, Steven K. Clinton, Anne McTiernan, Teresa Norat, Konstantinos K. Tsilidis
Summary: A systematic review found strong evidence linking higher postdiagnosis body mass index (BMI) to increased all-cause mortality, breast cancer-specific mortality, and second primary breast cancer. Waist circumference, waist-hip-ratio, and weight change were also associated with breast cancer prognosis. Further research is needed to understand the impact of body composition on breast cancer outcomes.
INTERNATIONAL JOURNAL OF CANCER
(2023)
Review
Oncology
Nerea Becerra-Tomas, Katia Balducci, Leila Abar, Dagfinn Aune, Margarita Cariolou, Darren C. Greenwood, Georgios Markozannes, Neesha Nanu, Rita Vieira, Edward L. Giovannucci, Marc J. Gunter, Alan A. Jackson, Ellen Kampman, Vivien Lund, Kate Allen, Nigel T. Brockton, Helen Croker, Daphne Katsikioti, Deirdre McGinley-Gieser, Panagiota Mitrou, Martin Wiseman, Amanda J. Cross, Elio Riboli, Steven K. Clinton, Anne McTiernan, Teresa Norat, Konstantinos K. Tsilidis, Doris S. M. Chan
Summary: Little is known about the impact of diet on breast cancer prognosis. Systematic reviews and meta-analyses were conducted to summarize the evidence on postdiagnosis dietary factors and breast cancer outcomes from randomized controlled trials and observational studies. A total of 108 publications were identified, and the results generally showed limited or no significant associations between diet and breast cancer outcomes, except for some suggestive evidence related to dietary patterns, isoflavone intake, dietary fiber intake, and serum 25-hydroxyvitamin D levels.
INTERNATIONAL JOURNAL OF CANCER
(2023)
Review
Multidisciplinary Sciences
Akbar Javan Biparva, Samira Raoofi, Sima Rafiei, Maryam Masoumi, Maryam Doustmehraban, Farzaneh Bagheribayati, Elahe sadat Vaziri Shahrebabak, Zahra Noorani Mejareh, Saghar Khani, Bahare Abdollahi, Zahra Abedi Bafrajard, Shakila Sotoude Beidokhti, Seyedeh Fahimeh Shojaei, Mahdieh Rastegar, Fatemeh Pashazadeh Kan, Elmira Nosrati Sanjabad, Ahmad Ghashghaee
Summary: This study aims to investigate the prevalence of depression among women with breast cancer globally. The results showed that the prevalence of depression in women with breast cancer is 30.2%, with Pakistan having the highest (83%) prevalence of depression and Taiwan having the lowest (8.3%). The prevalence of depression among women with breast cancer increases with age.
Review
Oncology
Hari Setyowibowo, Whisnu Yudiana, Joke A. M. Hunfeld, Aulia Iskandarsyah, Jan Passchier, Homra Arzomand, Sawitri S. Sadarjoen, Ralph de Vries, Marit Sijbrandij
Summary: The study found that psychoeducation did not significantly affect adherence to diagnostic procedures and medical treatment, depression, and BC knowledge, but it was beneficial for reducing anxiety and improving quality of life.
Review
Medicine, General & Internal
Aurelie Degeneffe, Viviane De Maertelaer, Olivier De Witte, Florence Lefranc
Summary: A comprehensive review and meta-analysis was conducted on the association between meningioma and breast cancer, revealing a nearly 10-fold higher odds of breast cancer in female patients with meningioma compared with the general population. It is recommended to screen female patients with meningioma more intensively for breast cancer.
Review
Oncology
Claudia A. Bargon, Danny A. Young-Afat, Mehmet Ikinci, Assa Braakenburg, Hinne A. Rakhorst, Marc A. M. Mureau, Helena M. Verkooijen, Annemiek Doeksen
Summary: The oncological safety of different types and timings of postmastectomy breast reconstruction (PMBR) remains controversial. This study found that delayed autologous PMBR leads to similar (loco)regional recurrence rates as immediate autologous PMBR. Current evidence suggests that oncological concerns should not be a reason to withhold patients from certain reconstructive timings or techniques, and patients should be offered all technically qualified reconstructive options equally.
Review
Biochemistry & Molecular Biology
Alejandro Garrido-Palacios, Ana Maria Rojas Carvajal, Ana Maria Nunez-Negrillo, Jonathan Cortes-Martin, Juan Carlos Sanchez-Garcia, Maria Jose Aguilar-Cordero
Summary: This systematic review and meta-analysis investigated dysregulated miRNA biomarkers and their diagnostic accuracy in breast cancer. The study found that 34 microRNAs were significantly dysregulated and could be considered as biomarkers for breast cancer. Individually, miR-155 showed better diagnostic results compared to mammography. However, using a panel of multiple miRNAs improved sensitivity and specificity rates, and they can be associated with classic biomarkers such as CA-125 or CEA. Based on the results, miR-155 holds promise as a diagnostic biomarker for breast cancer.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
(2023)
Review
Psychology, Multidisciplinary
Edith Meszaros Crow, Rosa Lopez-Gigosos, Eloisa Mariscal-Lopez, Marina Agredano-Sanchez, Natalia Garcia-Casares, Alberto Mariscal, Mario Gutierrez-Bedmar
Summary: Cancer initiation, progression, and recurrence are complex mechanisms that involve various components such as genetics, psychophysiology, and environment. Chronic exposure to stress, including fear of recurrence, can impact biological processes, increase cancer risk, and influence survival rates. Psychological interventions have been shown to influence cortisol levels, a biomarker for stress. This meta-analysis aimed to quantify the effect of psychosocial interventions on cortisol levels in saliva or blood, and its potential impact on breast cancer progression.
FRONTIERS IN PSYCHOLOGY
(2023)
Review
Oncology
May Soe Thu, Korn Chotirosniramit, Tanawin Nopsopon, Nattiya Hirankarn, Krit Pongpirul
Summary: This study evaluates microbial alterations in breast cancer patients compared to control subjects and explores intestinal microbial modifications from various breast cancer treatments. The results show an increase in gut and breast bacterial species in breast tumor cases, specifically a significant increase in Methylobacterium radiotolerans compared to healthy breast tissue. Additionally, patients with breast cancer have lower intestinal microbial diversity. Qualitative analysis identifies microbial abundance patterns in different sample types, detection methods, menopausal status, nationality, obesity, sleep quality, and various interventions.
FRONTIERS IN ONCOLOGY
(2023)
Review
Oncology
Bolette S. Rafn, Jan Christensen, Anders Larsen, Kira Bloomquist
Summary: The study found that participation in prospective surveillance with early management can reduce the risk of chronic lymphedema in breast cancer patients. Only a small number of patients who are at high risk of lymphedema due to axillary surgery develop chronic lymphedema. More research is needed to determine whether prospective surveillance with early management can reduce the risk of chronic lymphedema, especially for cancer survivors other than breast cancer.
JOURNAL OF CLINICAL ONCOLOGY
(2022)
Review
Pharmacology & Pharmacy
Yuxiu Xie, Men Wang, Peng Xu, Yujiao Deng, Yi Zheng, Si Yang, Ying Wu, Zhen Zhai, Dai Zhang, Na Li, Nan Wang, Jing Cheng, Zhijun Dai
Summary: This study found that the use of BBs, CCBs, and diuretics is associated with an increased risk of breast cancer, while long-term use of RASIs may reduce this risk. It also suggests that diuretic users may have a higher risk of breast cancer-specific mortality.
FRONTIERS IN PHARMACOLOGY
(2021)
Review
Oncology
Yalan Zhang, Fan Liu, Qianqian Gao, Yahui Chai, Yan Ren, Hongyou Tian, Bin Ma, Ailin Song
Summary: This study compared the outcomes between multiple malignant breast cancer (MMBC) and unifocal breast cancer (UFBC). The results suggest that MMBC patients may have a higher risk of death, but it may not be independently associated with poorer outcomes.
FRONTIERS IN ONCOLOGY
(2022)
Review
Medicine, General & Internal
Anam N. Ehsan, Catherine A. Wu, Alexandra Minasian, Tavneet Singh, Michelle Bass, Lydia Pace, Geoffrey C. Ibbotson, Nefti Bempong-Ahun, Andrea Pusic, John W. Scott, Rania A. Mekary, Kavitha Ranganathan
Summary: The study aimed to quantify the financial toxicity rate of patients with breast cancer and identify vulnerable populations. The analysis showed that breast cancer patients worldwide face high out-of-pocket costs and financial burden. Financial toxicity was more severe in low- and middle-income countries, but even in high-income countries, over 30% of patients experienced financial distress. Policies are needed to alleviate the financial burden and improve the financial well-being of breast cancer patients.
